The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Cyclin-Mediated Inhibition of Muscle Gene Expression via a Mechanism That Is Independent of pRB Hyperphosphorylation
Open accessAbstract
It was recently demonstrated that ectopic expression of cyclin D1 inhibits skeletal muscle differentiation and, conversely, that expression of cyclin-dependent kinase (cdk) inhibitors facilitates activation of this differentiation program (S. S. Rao, C. Chu, and D. S. Kohtz, Mol. Cell. Biol. 14:5259-5267, 1994; S. S. Rao and D. S. Kohtz, J. Biol. Chem. 270:4093-4100, 1995; S. X. Skapek, J. Rhee, D. B. Spicer, and A. B. Lassar, Science 267:1022-1024, 1995). Here we demonstrate that cyclin D1 inhibits muscle gene expression without affecting MyoD DNA binding activity. Ectopic expression of cyclin D1 inhibits muscle gene activation by both MyoD and myogenin, including a mutated form of myogenin in which two potential inhibitory cdk phosphorylation sites are absent. Because the retinoblastoma gene product, pRB, is a known target for cyclin D1-cdk phosphorylation, we determined whether cyclin D1-mediated inhibition of myogenesis was due to hyperphosphorylation of pRB. In pRB-deficient fibroblasts, the ability of MyoD to activate the expression of muscle-specific genes requires coexpression of ectopic pRB (B. G. Novitch, G. J. Mulligan, T. Jacks, and A. B. Lassar, J. Cell Biol., 135:441-456, 1996). In these cells, the expression of cyclins A and E can lead to pRB hyperphosphorylation and can inhibit muscle gene expression. The negative effects of cyclins A or E on muscle gene expression are, however, reversed by the presence of a mutated form of pRB which cannot be hyperphosphorylated. In contrast, cyclin D1 can inhibit muscle gene expression in the presence of the nonhyperphosphorylatable form of pRB. On the basis of these results we propose that G1 cyclin-cdk activity blocks the initiation of skeletal muscle differentiation by two distinct mechanisms: one that is dependent on pRB hyperphosphorylation and one that is independent of pRB hyperphosphorylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 1×
“Cyclin-dependent regulation of muscle gene expression in mitogen-stimulated myoblasts seems to be biologically relevant because forced expression of a combination of cdk inhibitors, p16 (64) and p21 (12, 19, 25, 52, 77), in nearly confluent, mitogen-stimulated myoblasts facilitates muscle differentiation in the absenc…”
BackgroundCloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
The MyoD family and myogenesis: Redundancy, networks, and thresholds
Weintraub, H. (1993) · Cell · doi:10.1016/0092-8674(93)90610-3 · Cited by 1,057 · cited 1×
“Skeletal muscle differentiation is coordinated by the activities of the myogenic basic helix-loop-helix (bHLH) transcription factors (5, 13, 39, 57, 75) and by members of the MEF2 family of transcriptional activators (reviewed in reference 58).”
BackgroundFunctional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
Jen, Y., Weintraub, H., & Benezra, R. (1992) · Genes & Development · doi:10.1101/gad.6.8.1466 · Cited by 471 · cited 2×
“myogenic differentiation, and delays skeletal muscle differentiation when constitutively expressed (30).”
Background
Cited by
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Minireview: Cyclin D1: Normal and Abnormal Functions
Fu, M., Wang, C., Li, Z., Sakamaki, T., & Pestell, R. G. (2004) · Endocrinology · doi:10.1210/en.2004-0959 · Cited by 966
The molecular regulation of myogenesis
Sabourin, L. A., & Rudnicki, M. A. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.570103.x · Cited by 726
Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases
Hydbring, P., Malumbres, M., & Sicinski, P. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.27 · Cited by 528
Linking cyclins to transcriptional control
Coqueret, O. (2002) · Gene · doi:10.1016/s0378-1119(02)01055-7 · Cited by 431
p21CIP1 and p57KIP2 control muscle differentiation at the myogenin step
Zhang, P., Wong, C., Liu, D., Finegold, M., Harper, J. W., & Elledge, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.2.213 · Cited by 409
NF-κB and cell-cycle regulation: the cyclin connection
JOYCE, D., ALBANESE, C., STEER, J., FU, M., BOUZAHZAH, B., & PESTELL, R. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00018-6 · Cited by 393
Pestell, R. G., Albanese, C., Reutens, A. T., Segall, J. E., Lee, R. J., & Arnold, A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0373 · Cited by 375
Molecular mechanisms regulating myogenic determination and differentiation
Perry, R. (2000) · Frontiers in Bioscience · doi:10.2741/perry · Cited by 369
Bennett, A. M., & Tonks, N. K. (1997) · Science · doi:10.1126/science.278.5341.1288 · Cited by 359
Mammalian Circadian Autoregulatory Loop
Sangoram, A. M., Saez, L., Antoch, M. P., Gekakis, N., Staknis, D., Whiteley, A., Fruechte, E. M., Vitaterna, M. H., Shimomura, K., King, D. P., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80627-3 · Cited by 357
Acetylation of MyoD Directed by PCAF Is Necessary for the Execution of the Muscle Program
Sartorelli, V., Puri, P. L., Hamamori, Y., Ogryzko, V., Chung, G., Nakatani, Y., Wang, J. Y. J., & Kedes, L. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80383-4 · Cited by 356
Cell cycle exit upon myogenic differentiation
Walsh, K., & Perlman, H. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80005-6 · Cited by 325
Zhang, P., Wong, C., DePinho, R. A., Harper, J. W., & Elledge, S. J. (1998) · Genes & Development · doi:10.1101/gad.12.20.3162 · Cited by 309
Puri, P. L., & Sartorelli, V. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200011)185:2<155::aid-jcp1>3.0.co;2-z · Cited by 292
Rhabdomyosarcoma – working out the pathways
Merlino, G., & Helman, L. J. (1999) · Oncogene · doi:10.1038/sj.onc.1203038 · Cited by 271
Mal, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1739 · Cited by 259
A Novel Rb- and p300-Binding Protein Inhibits Transactivation by MyoD
MacLellan, W. R., Xiao, G., Abdellatif, M., & Schneider, M. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8903-8915.2000 · Cited by 125
“In skeletal muscle, substantial precedent has been established for the pivotal role played in these reciprocal events by developmentally regulated expression of cyclins, Cdks, and Cdk inhibitors, especially G1 cyclins (21, 51, 63), although differing domains within Rb are now thought to mediate growth control versus d…”
BackgroundRegulation of cell lineage specification by the retinoblastoma tumor suppressor
Skapek, S. X., Pan, Y.-R., & Lee, E. Y.-H. P. (2006) · Oncogene · doi:10.1038/sj.onc.1209710 · Cited by 34
“…/ myoblasts and MEFs expressing the myogenic transcription factor MyoD showed that RB is required for myogenic transcription factors to highly induce certain muscle-specific genes (Novitch et al., 1996; Skapek et al., 1996) and promote cell cycle exit (Schneider et al., 1994; Novitch et al., 1996).”
BackgroundSelf-citation
Metadata
- Authors
- Skapek, S. X., Rhee, J., Kim, P. S., Novitch, B. G., & Lassar, A. B.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1996-12-01
- Volume
- 16
- Issue
- 12
- Pages
- 7043-7053
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2140753049
- Cited by
- 137
- References
- 7
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.